The Novel Antibody Therapeutics Congress 2019 will feature talks on the discoveries and developments of antibody-based cancer therapies. The talks will review the recent developments in bispecific antibody technology, as well as the potential of new antibody and antibody-mimicking formats. A dedicated checkpoint blockades session will also examine new approaches in neutralizing cancer cell immune blockades, including advances in PD1, PD-L1, and CTLA4 targeting therapeutics, and the discovery and targeting of new biomarkers. As one of the dominant biologic formats, monoclonal antibodies stand ready to capitalize on this, building on two decades offered of exciting advancements in the treatment of cancer.
Along with this congress, get access to 100+ presentations in four other co-located meetings:
Date: 10th-11th October 2019 | 9.00 am – 5.00 pm
Venue: London Heathrow Marriott Hotel, Bath Road Heathrow Airport, Hayes UB3 5AN
Website: http://www.global-engage.com/event/novel-antibody-congress/
For any inquiries, please contact:
Jane Williams | jane@globalengage.co.uk | (0)1865 849841
Analytica Anacon India, India Lab Expo, and Pharma Pro&Pack Expo host an impressive array of…
Thailand LAB INTERNATIONAL & Bio Asia Pacific 2023 set a new record with the highest…
Explore the Future of Healthcare and Wellness at the 6th Edition of PHILMEDICAL Expo 2023:…
Explore the latest solutions for Laboratories, Smart Health, Life Sciences, and Chemistry industries, for all…
Now incorporating CHEMLAB | FOODLAB | ENVIROLAB | IPETROLAB BIGGER THAN EVER!! This is your personal…
INALAB 2023, together with Food Manufacturing Indonesia 2023, Chemical Indonesia 2023, Smart Factory Indonesia 2023,…